- Home
- FTLF vs IPHA Comparison
FTLF vs IPHA Comparison
Compare FTLF & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTLF
- IPHA
- Stock Information
- Founded
- FTLF 2005
- IPHA 1999
- Country
- FTLF United States
- IPHA France
- Employees
- FTLF N/A
- IPHA N/A
- Industry
- FTLF Medicinal Chemicals and Botanical Products
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- FTLF Health Care
- IPHA Health Care
- Exchange
- FTLF Nasdaq
- IPHA Nasdaq
- Market Cap
- FTLF 149.3M
- IPHA 160.1M
- IPO Year
- FTLF N/A
- IPHA 2019
- Fundamental
- Price
- FTLF $19.74
- IPHA $1.98
- Analyst Decision
- FTLF Strong Buy
- IPHA Hold
- Analyst Count
- FTLF 2
- IPHA 2
- Target Price
- FTLF $23.00
- IPHA $2.00
- AVG Volume (30 Days)
- FTLF 16.3K
- IPHA 21.7K
- Earning Date
- FTLF 11-13-2025
- IPHA 09-17-2025
- Dividend Yield
- FTLF N/A
- IPHA N/A
- EPS Growth
- FTLF N/A
- IPHA N/A
- EPS
- FTLF 0.80
- IPHA N/A
- Revenue
- FTLF $63,053,000.00
- IPHA $14,839,695.00
- Revenue This Year
- FTLF $34.34
- IPHA $350.96
- Revenue Next Year
- FTLF $48.58
- IPHA $32.92
- P/E Ratio
- FTLF $24.87
- IPHA N/A
- Revenue Growth
- FTLF 3.91
- IPHA N/A
- 52 Week Low
- FTLF $9.83
- IPHA $1.29
- 52 Week High
- FTLF $20.27
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- FTLF 61.64
- IPHA 49.88
- Support Level
- FTLF $19.56
- IPHA $1.95
- Resistance Level
- FTLF $20.15
- IPHA $2.10
- Average True Range (ATR)
- FTLF 0.51
- IPHA 0.09
- MACD
- FTLF -0.05
- IPHA 0.02
- Stochastic Oscillator
- FTLF 71.35
- IPHA 52.72
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.